ABCG2 and Hodgkins lymphoma: Regarding ADCs, MDR1 upregulation was related to poor prognosis in patients with Hodgkin lymphoma who received brentuximab vedotin, an ADC for CD30 incorporated MMAE; however, it was not referred to as whether specific SNVs of ABC transporter regarding MMAE [34].